Articles with public access mandates - William HopeLearn more
Not available anywhere: 11
Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
J Lestner, WW Hope
Expert opinion on drug metabolism & toxicology 9 (7), 911-926, 2013
Mandates: UK Medical Research Council
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
MC Arendrup, M Cuenca-Estrella, C Lass-Flörl, WW Hope
Drug Resistance Updates 16 (6), 81-95, 2013
Mandates: US National Institutes of Health, Austrian Science Fund, Government of Spain
Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung
KA Rodvold, WW Hope, SE Boyd
Current Opinion in Pharmacology 36, 114-123, 2017
Mandates: UK Medical Research Council, National Institute for Health Research, UK
EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole
M Cavling Arendrup, M Cuenca‐Estrella, C Lass‐Flörl, WW Hope, ...
Mycoses 57 (6), 377-379, 2014
Mandates: US National Institutes of Health, National Institute for Health Research, UK …
Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis
LL Kovanda, R Maher, WW Hope
Expert Review of Clinical Pharmacology 9 (7), 887-897, 2016
Mandates: National Institute for Health Research, UK
Clinical pharmacology of antifungal agents in pediatrics: children are not small adults
V Ramos-Martín, O O’Connor, W Hope
Current Opinion in Pharmacology 24, 128-134, 2015
Mandates: National Institute for Health Research, UK
Pharmacokinetics–pharmacodynamics of antifungal agents in the central nervous system
KE Stott, W Hope
Expert Opinion on Drug Metabolism & Toxicology 14 (8), 803-815, 2018
Mandates: Wellcome Trust
Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance
PG Cojutti, C Barbarino, A De Monte, W Hope, F Pea
European Journal of Clinical Pharmacology 74, 1091-1092, 2018
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
PG Cojutti, M Lugano, E Righi, G Della Rocca, M Bassetti, W Hope, F Pea
European Journal of Clinical Pharmacology 74, 1449-1459, 2018
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Clinical utility of micafungin: pharmacokinetics, dosing, use in special populations and drug interactions
WW Hope, SJ Howard, TW Felton
Mycoses 55, 33-38, 2012
Mandates: US National Institutes of Health
Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development …
V Dubey, N Farrington, N Harper, A Johnson, I Horner, A Stevenson, ...
Antimicrobial Agents and Chemotherapy 68 (10), e00222-24, 2024
Mandates: UK Research & Innovation
Available somewhere: 169
Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clinical infectious diseases 46 (12), 1813-1821, 2008
Mandates: US National Institutes of Health
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ...
The Lancet infectious diseases 14 (6), 498-509, 2014
Mandates: US National Institutes of Health, National Health and Medical Research …
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013
OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ...
Clinical Microbiology and Infection 20, 5-26, 2014
Mandates: National Institute for Health Research, UK, Government of Spain
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
HR Ashbee, RA Barnes, EM Johnson, MD Richardson, R Gorton, ...
Journal of Antimicrobial Chemotherapy 69 (5), 1162-1176, 2014
Mandates: US National Institutes of Health, National Institute for Health Research, UK
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
MC Arendrup, T Boekhout, M Akova, JF Meis, OA Cornely, O Lortholary, ...
Clinical Microbiology and Infection 20, 76-98, 2014
Mandates: National Institute for Health Research, UK, Government of Spain
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
NRH Stone, T Bicanic, R Salim, W Hope
Drugs 76, 485-500, 2016
Mandates: National Institute for Health Research, UK, Wellcome Trust
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ...
Clinical Microbiology and Infection 20, 27-46, 2014
Mandates: National Institute for Health Research, UK, Government of Spain
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for …
MC Arendrup, M Cuenca‐Estrella, C Lass‐Flörl, W Hope, EUCAST‐AFST
Clinical Microbiology and Infection 18 (7), E246-E247, 2012
Mandates: US National Institutes of Health, Government of Spain
Therapy for fungal diseases: opportunities and priorities
DW Denning, WW Hope
Trends in microbiology 18 (5), 195-204, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program